The North America non-invasive aesthetic treatment market is expected to reach US$ 8,085.74 million by 2028 from US$ 3,126.34 million in 2021; it is estimated to grow at a CAGR of 14.5% from 2021 to 2028.
The growth of the market is attributed to a few key driving factors such as rising number of non-invasive aesthetic/cosmetic procedures performed every year and surging awareness about cosmetic procedures among consumers. However, clinical risks and complications associated with medical aesthetic procedures is hindering the market growth.
Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their non-invasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Therefore, the advantages of minimally invasive procedures over conventional surgery—such as faster recovery, reduced pain, and shortened hospital stays, and greater efficiency rate—contribute to the non-invasive aesthetic treatment market growth. As per the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, ~3.8 million minimally invasive cosmetic operations were performed in the US in people with age 55 and above. The advancements in nonsurgical technologies and unveiling of new surgery options have made aesthetics accessible to people. For example, the advantages of laser procedures have attracted younger people to improve their skin conditions, modify body parts, and correct their physical posture. Therefore, rising acceptance of non-invasive aesthetic/cosmetic procedures is driving the growth of the North America non-invasive aesthetic treatment market. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people, which is also boosting the market growth.
North America is highly affected due to the COVID-19 outbreak pandemic. In the US, due to an increasing number of infected patients, healthcare professionals and leading organizations distract the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges with diagnostics and bed availability. Moreover, high priorities for the diagnosis and treatment of COVID-19 are leading to decline in non-invasive aesthetic treatment, which is restraining the growth of the North America non-invasive aesthetic treatment market up to certain extent.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION
By Procedure
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
By End User
- Hospitals
- Clinics and Medical Spas
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Galderma
- Alma Lasers
- Merz Pharma
- Bausch Health Companies Inc.
- Cutera Inc.
- Revance Therapeutics Inc.
- Cynosure
- AbbVie Inc.
- Candela Medical
- Johnson and Johnson Services, Inc.
North America Non-Invasive Aesthetic Treatment Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 3,126.34 Million |
Market Size by 2028 | US$ 8,085.74 Million |
Global CAGR (2021 - 2028) | 14.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Procedure
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Procedure and End User

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Galderma
- Alma Lasers
- Merz Pharma
- Bausch Health Companies Inc.
- Cutera Inc.
- Revance Therapeutics Inc.
- Cynosure
- AbbVie Inc.
- Candela Medical
- Johnson and Johnson Services, Inc.